X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cholesterol, ldl - blood (3) 3
double-blind method (3) 3
female (3) 3
fluorobenzenes - therapeutic use (3) 3
humans (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
male (3) 3
pyrimidines - therapeutic use (3) 3
risk (3) 3
rosuvastatin calcium (3) 3
sulfonamides - therapeutic use (3) 3
aged (2) 2
c-reactive protein - analysis (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular diseases - prevention & control (2) 2
coronary-heart-disease (2) 2
index medicus (2) 2
inflammation (2) 2
metabolic syndrome - epidemiology (2) 2
middle aged (2) 2
myocardial infarction - epidemiology (2) 2
myocardial infarction - prevention & control (2) 2
pravastatin (2) 2
risk factors (2) 2
statin therapy (2) 2
statins (2) 2
stroke - epidemiology (2) 2
stroke - prevention & control (2) 2
abridged index medicus (1) 1
age factors (1) 1
apparently healthy-men (1) 1
aspirin (1) 1
biomarkers (1) 1
biomarkers - blood (1) 1
body mass index (1) 1
c-reactive protein (1) 1
c-reactive protein - metabolism (1) 1
cardiovascular disease (1) 1
cardiovascular diseases (1) 1
cardiovascular diseases - blood (1) 1
cardiovascular diseases - epidemiology (1) 1
cardiovascular diseases - mortality (1) 1
cardiovascular-disease (1) 1
cholesterol (1) 1
continental population groups (1) 1
density-lipoprotein cholesterol (1) 1
diabetes mellitus - chemically induced (1) 1
disease (1) 1
drug therapy (1) 1
endpoint determination (1) 1
epidemiology (1) 1
fluorobenzenes - adverse effects (1) 1
follow-up studies (1) 1
glycated hemoglobin a - metabolism (1) 1
health aspects (1) 1
heart attacks (1) 1
hospitalization - statistics & numerical data (1) 1
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1) 1
jupiter trial (1) 1
kaplan-meier estimate (1) 1
lipid-levels (1) 1
long-term mortality (1) 1
lovastatin - therapeutic use (1) 1
medicine, general & internal (1) 1
metabolic syndrome (1) 1
metabolic syndrome - drug therapy (1) 1
multicenter studies as topic (1) 1
muscular diseases - chemically induced (1) 1
myocardial revascularization (1) 1
myocardial-infarction (1) 1
outcomes research (1) 1
peripheral vascular disease (1) 1
prediction (1) 1
prevention (1) 1
prevention and control (1) 1
primary prevention (1) 1
prognostic value (1) 1
proportional hazards models (1) 1
proteins (1) 1
pyrimidines - adverse effects (1) 1
randomized controlled trials as topic (1) 1
randomized-trial (1) 1
research design (1) 1
rosuvastatin (1) 1
sulfonamides - adverse effects (1) 1
therapy (1) 1
usage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2008, Volume 359, Issue 21, pp. 2195 - 2207
In this trial, 17,802 healthy men and women with low-density lipoprotein cholesterol levels of less than 130 mg per deciliter and high-sensitivity C-reactive... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | APPARENTLY HEALTHY-MEN | STATIN THERAPY | INFLAMMATION | CARDIOVASCULAR-DISEASE | JUPITER TRIAL | RISK | PRAVASTATIN | CORONARY-HEART-DISEASE | PREDICTION | Myocardial Infarction - epidemiology | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | C-Reactive Protein - metabolism | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Stroke - epidemiology | Muscular Diseases - chemically induced | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Rosuvastatin Calcium | Biomarkers - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Diabetes Mellitus - chemically induced | Aged | Fluorobenzenes - adverse effects | Myocardial Infarction - prevention & control | Fluorobenzenes - therapeutic use | Prevention | Usage | C-reactive protein | Rosuvastatin | Cardiovascular diseases | Drug therapy | Health aspects | Proteins | Cardiovascular disease | Heart attacks | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Circulation. Cardiovascular quality and outcomes, ISSN 1941-7713, 2009, Volume 2, Issue 6, pp. 616 - 623
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.